The 81st Annual Meeting of the Japanese Society of Hematology

Presentation information

Print

Oral Session

Oral Session 3-11B CML: Clinical (1)

Sun. Oct 13, 2019 10:10 AM - 11:10 AM No.11 (Tokyo International Forum, 5F G502)

Chair: Michihide Tokuhira (Department of Hematology, Saitama Medical Center, Saitama Medical University)

[OS3-11B-6] 2nd line tyrosine kinase inhibitor dasatinib affected PSA levels in peripheral blood in CML patients

Kohshi Ohishi1, Takeshi Sasaki2, Naoto Takahashi3, Naoyuki Katayama4 (1.Trans. Med. Cell Ther, Mie Univ. Hos., Tsu, Japan, 2.Dep. of Nephro-Urol Surg. and Androl., Mie Univ., Tsu, Japan, 3.Dep. of Hematol, Nephrol., Rheumatol, Akita Univ., Akita, Japan, 4.Dep. of Hematol. and Oncol., Mie Univ., Tsu, Japan)

Abstract password authentication.
Password is required to view the abstract. Please enter a password to authenticate.Password is written on a program book.

Password